Eisai
4523.T
#2332
Rank
A$11.74 B
Marketcap
A$41.62
Share price
0.23%
Change (1 day)
-4.48%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.24. In 2026 the company made an earnings per share (EPS) of A$1.23 a decrease over its 2025 EPS that were of A$1.56.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.23-21.04%
2025A$1.5611.85%
2024A$1.40-32.63%
2023A$2.075.52%
2022A$1.97-74.01%
2021A$7.56-66.58%
2020A$22.6298.24%
2019A$11.4117.01%
2018A$9.7537.78%
2017A$7.08-27.62%
2016A$9.7835.33%
2015A$7.23-2.82%
2014A$7.44-27.66%
2013A$10.28-27.49%
2012A$14.18-12.67%
2011A$16.2388.08%
2010A$8.63-11.06%
2009A$9.71-390.15%
2008A-$3.34-127.78%
2007A$12.04347.11%
2006A$2.694.38%
2005A$2.587.4%
2004A$2.4043.03%
2003A$1.6825.09%
2002A$1.3452.67%
2001A$0.8869.76%
2000A$0.52